Delivery Order SPE2DR25D1007-SPE2DR26FY8DA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $9,366.47. This competitive, firm fixed-price delivery order is expected to be completed by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Eliquis 5 mg tablets in a 60-count quantity, with a firm fixed price ceiling value of $2,273.15 and a completion date of November 6, 2025. This non-set-aside, competitively awarded contract was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $16,480.94. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 9, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $1,988.27. This firm fixed-price delivery order is due for completion by November 6, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition without set-aside designation, reflecting AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Eliquis 5 mg tablets (60-count package) with a firm fixed price ceiling value of $6,625.72 and an ultimate completion date of November 4, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $11,138.41. This firm fixed-price delivery order, with an ultimate completion date of October 29, 2025, is issued without a set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a contract value of $2,491.80. This is a firm fixed price delivery order with an ultimate completion date of October 27, 2025, and represents a non-competitive set-aside award. AmerisourceBergen will perform this work from its corporate headquarters in Conshohocken, Pennsylvania, where the company maintains operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units) at a ceiling value of $1,965.60. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of October 30, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,138.46 on October 22, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 23, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D1007Indefinite Delivery Contract
- SPE2DR25D1007-SPE2DR26FY8DADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Eliquis 5 mg tablets in a 60-count package. This contract is a non-set-aside, competitively awarded delivery order with a firm fixed price ceiling value of $12,911.85 and an ultimate completion date of November 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle supporting military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems through the Defense Logistics Agency. The company's extensive federal contract portfolio demonstrates its capability to fulfill complex medical procurement requirements across multiple therapeutic domains on a competitive basis. This delivery order for Eliquis, an anticoagulant medication, represents a routine transaction within AmerisourceBergen's ongoing supply relationship with the Defense Logistics Agency Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 11/7/25 |